JCRRF (JCR Pharmaceuticals Co) EV-to-FCF: (As of Jul. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

JCRRF JCR Pharmaceuticals Co Ltd JCRRF
55 GF Score
Price $3.31
GF Value $5.64
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is JCR Pharmaceuticals Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, JCR Pharmaceuticals Co's Enterprise Value is $608.1 Mil. JCR Pharmaceuticals Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $0.0 Mil. Therefore, JCR Pharmaceuticals Co's EV-to-FCF for today is .

The historical rank and industry rank for JCR Pharmaceuticals Co's EV-to-FCF or its related term are showing as below:

JCRRF' s EV-to-FCF Range Over the Past 10 Years
Min: -8.41   Med: 0   Max: 0
Current: -8.41

JCRRF's EV-to-FCF is ranked worse than
100% of 564 companies
in the Drug Manufacturers industry
Industry Median: 20.895 vs JCRRF: -8.41

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-07-15), JCR Pharmaceuticals Co's stock price is $3.31. JCR Pharmaceuticals Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $0.118. Therefore, JCR Pharmaceuticals Co's PE Ratio (TTM) for today is 28.05.


JCR Pharmaceuticals Co  (OTCPK:JCRRF) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

JCR Pharmaceuticals Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=3.31/0.118
=28.05

JCR Pharmaceuticals Co's share price for today is $3.31.
JCR Pharmaceuticals Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.118.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


JCR Pharmaceuticals Co EV-to-FCF Related Terms


JCR Pharmaceuticals Co EV-to-FCF Historical Data

* Premium members only.

The historical data trend for JCR Pharmaceuticals Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JCR Pharmaceuticals Co EV-to-FCF Chart

JCR Pharmaceuticals Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -125.90 -13.23 14.36 -5.45 -9.35

JCR Pharmaceuticals Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.45 0.00 0.00 0.00 -9.35

JCRRF vs LLY, JNJ, ABBV: EV-to-FCF Comparison

For the Drug Manufacturers - General subindustry, JCR Pharmaceuticals Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JCR Pharmaceuticals Co EV-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, JCR Pharmaceuticals Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where JCR Pharmaceuticals Co's EV-to-FCF falls into.


JCRRF
55GF Score
JCR Pharmaceuticals Co Ltd JCRRF
EV-to-FCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

JCR Pharmaceuticals Co EV-to-FCF Calculation

JCR Pharmaceuticals Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=608.125/0
=

JCR Pharmaceuticals Co's current Enterprise Value is $608.1 Mil.
JCR Pharmaceuticals Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is JCR Pharmaceuticals Co (JCRRF) Overvalued in 2026?

Based on GuruFocus' analysis, JCR Pharmaceuticals Co stock appears to be undervalued. The current stock price of $3.31 is trading 41.3% below its estimated GF Value™ of $5.64. GuruFocus considers JCR Pharmaceuticals Co to be Possible Value Trap.

Key valuation signals for JCRRF:

  • EV-to-FCF:
  • GF Value™: $5.64 vs. price of $3.31 (41.3% below fair value)
  • GF Score™: 55/100 with 7 warning signs

No single metric tells the full story. See the JCRRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


JCR Pharmaceuticals Co Business Description

Other Exchanges 4552:Japan
Address 3-19 Kasuga-cho, Ashiya, Hyogo, JPN, 659-0021
JCR Pharmaceuticals Co Ltd is a major drug manufacturing company proactively engaged in the research of enzymes and proteins. The company maintains a focus toward developing value-added treatment options to address unmet medical needs. JCR utilizes international partnerships as a component of its growth strategy. The vast majority of JCR's revenue is generated from its pharmaceutical operations, followed by medical devices and laboratory equipment. A portion of the company's sales are derived from licensing agreements.
55GF Score

Get the complete analysis for JCRRF

EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.31
Price
$5.64
GF Value